MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
557.68%
Quick Ratio
557.68%
Cash Ratio
533.44%
Debt to Asset Ratio
71.73%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Other prepaid expenses and curre...
    • Prepaid clinical trial expenses
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Promissory note
    • Others
Balance Sheets
2026-06-30
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
18,617
11,520
5,470
5,918
Short-term investments
0
1,496
8,614
12,039
Prepaid clinical trial expenses
228
201
230
352
Other prepaid expenses and current assets
575
259
539
655
Assets held for sale
43
54
-
-
Total current assets
19,463
13,530
14,853
18,964
Property and equipment, net
36
50
49
105
Other assets
4
11
11
11
Total assets
19,503
13,591
14,913
19,080
Accounts payable
2,073
1,161
1,133
1,912
Accrued clinical trial costs
193
1,081
1,523
670
Accrued expenses
1,224
290
1,025
895
Current portion, promissory note
0
1,250
-
-
Total current liabilities
3,490
3,782
3,681
3,477
Promissory note
9,200
8,450
8,900
8,500
Warrant liability
1,300
8,000
2,600
1,000
Total liabilities
13,990
20,232
15,181
12,977
Common stock, 0.0001 par value 500,000,000 shares authorized at june 30, 2026 and december 31, 2025, respectively 30,736,401 and 15,437,410, issued and outstanding at june 30, 2026 and december 31, 2025, respectively
6
4
4
4
Additional paid-in capital
197,510
182,681
178,293
176,865
Accumulated deficit
-192,002
-189,326
-178,566
-170,762
Accumulated other comprehensive loss
-1
0
1
-4
Total stockholders' equity (deficit)
5,513
-6,641
-268
6,103
Total liabilities and stockholders' equity (deficit)
19,503
13,591
14,913
19,080
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$18,617K (214.58%↑ Y/Y)Other prepaidexpenses and current...$575K (-12.21%↓ Y/Y)Prepaid clinical trialexpenses$228K (-35.23%↓ Y/Y)Assets held for sale$43K Total current assets$19,463K (2.63%↑ Y/Y)Property and equipment,net$36K (-65.71%↓ Y/Y)Other assets$4K (-63.64%↓ Y/Y)Total assets$19,503K (2.22%↑ Y/Y)Total liabilities andstockholders' equity...$19,503K (2.22%↑ Y/Y)Total liabilities$13,990K (7.81%↑ Y/Y)Total stockholders'equity (deficit)$5,513K (-9.67%↓ Y/Y)Accumulated deficit-$192,002K (-12.44%↓ Y/Y)Accumulated othercomprehensive loss-$1K (75.00%↑ Y/Y)Promissory note$9,200K (8.24%↑ Y/Y)Total currentliabilities$3,490K (0.37%↑ Y/Y)Warrant liability$1,300K (30.00%↑ Y/Y)Additional paid-in capital$197,510K (11.67%↑ Y/Y)Common stock, 0.0001par value...$6K (50.00%↑ Y/Y)Accounts payable$2,073K (8.42%↑ Y/Y)Accrued expenses$1,224K (36.76%↑ Y/Y)Accrued clinical trialcosts$193K (-71.19%↓ Y/Y)

CalciMedica, Inc. (CALC)

CalciMedica, Inc. (CALC)